Trials / Sponsors / Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia Postoperative Analgesia | Phase 3 | 2024-08-07 |
| Completed | Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection Pain | Phase 1 | 2023-12-20 |
| Completed | Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Imp Infections Caused by Anaerobic Bacteria, Renal Impairment | Phase 1 | 2023-10-30 |
| Completed | A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-A Intraabdominal Infections | Phase 4 | 2023-05-10 |